Back to Search
Start Over
Supplementary Data from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Data from First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....0528c7584af822078d30d2eaa31153f3
- Full Text :
- https://doi.org/10.1158/1078-0432.22486697.v1